Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

European Infant Neuroblastoma Study - Stage 2, 3, 4, and 4S; MYCN Amplified Tumors

NCT00025649 is registered in ClinicalTrials.gov with European Infant Neuroblastoma Study Group - 1999 as lead sponsor.

NCT NCT00025649
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00025649 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
European Infant Neuroblastoma Study - Stage 2, 3, 4, and 4S; MYCN Amplified Tumors
Lead sponsor
European Infant Neuroblastoma Study Group - 1999
Phase
Phase 2
Overall status
Completed
Start date
July 31, 1999
Completion date
March 31, 2009
Enrollment
Not reported
Sites
11

Conditions

As the registry lists them; a condition with its own page is linked.

neuroblastoma